ArticleJournal for immunotherapy of cancer2025

Targeting immunosuppressive macrophages by CSRP2-regulated CCL28 signaling sensitizes hepatocellular carcinoma to lenvatinib.

Changzhou Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.